Improving the efficiency of liver targeting rAAV-mediated homologous recombination using ribonucleotide reductase inhibitors
Shinnosuke Tsuji(Stanford University), Mark A. Kay(Io Therapeutics (United States))
Cited by 0
Related Papers
The miR-363-GATA6-Lgr5 pathway is critical for colorectal tumourigenesis
|Nature Communications|2014|91
Genome engineering with Cas9 and AAV repair templates generates frequent concatemeric insertions of viral vectors
|Nature Biotechnology|2024|56
Selection of rAAV Vectors that Cross the Human Blood-Brain Barrier and Target the Central Nervous System Using a Transwell Model
|bioRxiv (Cold Spring Harbor Laboratory)|2022|1
Using a barcoded AAV capsid library to select for novel clinically relevant gene therapy vectors
|bioRxiv (Cold Spring Harbor Laboratory)|2019|0